A detailed history of Cetera Investment Advisers transactions in Pfizer Inc stock. As of the latest transaction made, Cetera Investment Advisers holds 2,062,488 shares of PFE stock, worth $51.4 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
2,062,488
Previous 2,110,531 2.28%
Holding current value
$51.4 Million
Previous $59.1 Million 1.08%
% of portfolio
0.14%
Previous 0.14%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$27.7 - $31.39 $1.33 Million - $1.51 Million
-48,043 Reduced 2.28%
2,062,488 $59.7 Million
Q2 2024

Aug 22, 2024

SELL
$25.26 - $29.6 $2.31 Million - $2.71 Million
-91,555 Reduced 4.16%
2,110,531 $59.1 Million
Q1 2024

May 24, 2024

BUY
$25.89 - $29.73 $48.2 Million - $55.4 Million
1,862,290 Added 548.06%
2,202,086 $61.1 Million
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $11.7 Million - $13.5 Million
-452,763 Reduced 57.13%
339,796 $9.43 Million
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $2.21 Million - $2.87 Million
-84,426 Reduced 9.63%
792,559 $22.8 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $1.26 Million - $1.47 Million
39,210 Added 4.68%
876,985 $29.1 Million
Q2 2023

Aug 09, 2023

BUY
$36.12 - $41.79 $552,310 - $639,010
15,291 Added 1.86%
837,775 $30.7 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $1.33 Million - $1.74 Million
33,882 Added 4.3%
822,484 $33.6 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $6.54 Million - $8.53 Million
156,576 Added 24.77%
788,602 $40.4 Million
Q3 2022

Nov 10, 2022

SELL
$43.76 - $53.42 $6.5 Million - $7.94 Million
-148,543 Reduced 19.03%
632,026 $27.7 Million
Q2 2022

Aug 11, 2022

BUY
$46.53 - $55.17 $77,705 - $92,133
1,670 Added 0.21%
780,569 $40.9 Million
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $1.34 Million - $1.67 Million
29,396 Added 3.92%
778,899 $40.3 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $304,073 - $450,738
7,359 Added 0.99%
749,503 $44.3 Million
Q3 2021

Nov 16, 2021

BUY
$39.25 - $50.42 $941,921 - $1.21 Million
23,998 Added 3.34%
742,144 $31.9 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $1.6 Million - $1.81 Million
44,425 Added 6.59%
718,146 $28.1 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $830,719 - $936,884
24,805 Added 3.82%
673,721 $24.4 Million
Q4 2020

Feb 17, 2021

BUY
$33.47 - $42.56 $18.2 Million - $23.1 Million
543,719 Added 516.86%
648,916 $23.9 Million
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $180,721 - $212,027
5,692 Added 5.72%
105,197 $3.86 Million
Q2 2020

Aug 13, 2020

BUY
$30.12 - $36.54 $793,933 - $963,157
26,359 Added 36.04%
99,505 $3.25 Million
Q1 2020

May 08, 2020

BUY
$27.03 - $38.62 $60,493 - $86,431
2,238 Added 3.16%
73,146 $2.39 Million
Q4 2019

Feb 10, 2020

BUY
$32.92 - $37.36 $98,430 - $111,706
2,990 Added 4.4%
70,908 $2.79 Million
Q3 2019

Nov 06, 2019

BUY
$32.49 - $42.13 $132,039 - $171,216
4,064 Added 6.36%
67,918 $2.45 Million
Q2 2019

Aug 12, 2019

BUY
$36.98 - $41.52 $70,927 - $79,635
1,918 Added 3.1%
63,854 $2.76 Million
Q1 2019

May 06, 2019

BUY
$37.5 - $41.2 $488,475 - $536,671
13,026 Added 26.63%
61,936 $2.62 Million
Q4 2018

Feb 15, 2019

SELL
$38.47 - $43.86 $56,666 - $64,605
-1,473 Reduced 2.92%
48,910 $2.13 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $88,450 - $107,284
2,566 Added 5.37%
50,383 $2.21 Million
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $78,525 - $83,715
2,381 Added 5.24%
47,817 $1.74 Million
Q1 2018

May 09, 2018

SELL
$31.91 - $37.02 $76,360 - $88,588
-2,393 Reduced 5.0%
45,436 $1.62 Million
Q4 2017

Feb 08, 2018

SELL
$33.26 - $35.29 $15,499 - $16,445
-466 Reduced 0.96%
47,829 $1.73 Million
Q3 2017

Nov 16, 2017

SELL
$31.0 - $34.15 $63,426 - $69,870
-2,046 Reduced 4.06%
48,295 $1.73 Million
Q2 2017

Aug 17, 2017

SELL
N/A
-57,743 Reduced 53.42%
50,341 $1.69 Million
Q2 2017

Aug 14, 2017

BUY
N/A
108,084
108,084 $3.62 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $140B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.